Session

Kidney transplantation: All about the graft and donation

Poster Session 76

  • Location:
    Room London, North Hall (Level 1)
  • Chairs:
     A. Alcaraz, Barcelona (ES)
     M. Stöckle, Homburg (DE)
     C. Terrone, Turin (IT)
  • Aims and objectives of this session

    This session covers different aspects on kidney donation and grafts including:
    – donor and kidney selection
    – development and treatment of tumors in the graft
    – experience with non-heartbeating donors

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
1003
Role of polyomavirus BK in the carcinogenesis of urothelial and renal tumours in kidney transplant recipients

By: Poletti F.1, Borgogna C.2, Billia M.1, Zacchero M.1, Boldorini R.3, Cantaluppi V.4, Gariglio M.2, Volpe A.1

Institutes: 1University of Eastern Piedmont, Dept. of Urology, Novara, Italy, 2University of Eastern Piedmont, Virology Unit, Novara, Italy, 3University of Eastern Piedmont, Dept. of Pathology, Novara, Italy, 4University of Eastern Piedmont, Dept. of Nephrology and Renal Transplantation, Novara, Italy

* 1004
De novo functional renal graft carcinomas: Are they a different entity ?

By: Tillou X.1, Bensadoun H.2, Bessede T.3, Bigot P.4, Boutin J-M.28, Bouyé S.5, Codas R.6, Cognard N.7, Coffin G.8, De Fortescu G.9, Devonec M.6, Erauso A.11, Gaudez F.10, Gigante M.18, Hubert J.12, Karam G.13, Laurent G.14, Lechevallier E.15, Mousson C.16, Rerolle J-P.17, Sallusto F.19, Salomon L.20, Sénéchal C.21, Terrier N.22, Timsit M-O.23, Thuret R.24, Toupance O.29, Verhoest G.25, Viart L.26, Doerfler A.27

Institutes: 1CHU Caen, Dept. of Urology and Transplantation, Caen, France, 2CHU De Bordeaux, Dept. of Urology and Transplantation, Bordeaux, France, 3CHU Kremlin Bicêtre, Dept. of Urology and Transplantation, Paris, France, 4CHU D’Angers, Dept. of Urology and Transplantation, Angers, France, 5CHRU De Lille, Dept. of Urology and Transplantation, Lille, France, 6CHU De Lyon, Dept. of Urology and Transplantation, Lyon, France, 7CHU De Strasbourg, Dept. of Urology and Transplantation, Strasbourg, France, 8CHU Pitié-Salpétrière, Dept. of Urology and Transplantation, Paris, France, 9CHU De Rouen, Dept. of Urology and Transplantation, Rouen, France, 10CHU Saint Louis, Dept. of Urology and Transplantation, Paris, France, 11CHU De Brest, Dept. of Urology and Transplantation, Brest, France, 12CHU De Nancy, Dept. of Urology and Transplantation, Nancy, France, 13CHU De Nantes, Dept. of Urology and Transplantation, Nantes, France, 14CHU De Clermont Ferrand, Dept. of Urology and Transplantation, Clermont Ferrand, France, 15CHU De Marseille, Dept. of Urology and Transplantation, Marseille, France, 16CHU De Dijon, Dept. of Urology and Transplantation, Dijon, France, 17CHU de Limoges, Dept. of Urology and Transplantation, Limoges, France, 18CHU De Nice, Dept. of Urology and Transplantation, Nice, France, 19CHU Rangeuil, Dept. of Urology and Transplantation, Toulouse, France, 20CHU Henri Mondor, Dept. of Urology and Transplantation, Paris Créteil, France, 21CHU Point À Pitre, Dept. of Urology and Transplantation, Guadeloupe, France, 22CHU De Grenoble, Dept. of Urology and Transplantation, Grenoble, France, 23HEGP, Dept. of Urology and Transplantation, Paris, France, 24CHU De Montpellier, Dept. of Urology and Transplantation, Montpellier, France, 25CHU De Rennes, Dept. of Urology and Transplantation, Rennes, France, 26CHU D’Amiens, Dept. of Urology and Transplantation, Amiens, France, 27CHU De Caen, Dept. of Urology and Transplantation, Caen, France, 28CHU De Tours, Dept. of Urology and Transplantation, Tours, France, 29CHU De Reims, Dept. of Nephrology, Tours, France

1005
Urothelial carcinoma after kidney transplant: A heterogeneus entity in terms of diagnosis, treatments and oncological outcomes

By: Hevia V., Lorca J., Gómez V., Donis F., Brasero J., Alvarez S., Díez V., Jiménez M.A., Burgos F.J.

Institutes: Hospital Universitario Ramón y Cajal, Dept. of Urology IRYCIS, Madrid, Spain

1006
Our experience in the management of prostate cancer in renal transplant recipients

By: Narváez Barros A., Riera Canals L., Fernández-Concha Schwalb J., Suarez Novo J., Castells Esteve M., Vigués Julià F.

Institutes: Bellvitge University Hospital, Dept. of Urology, Barcelona, Spain

1007
Effectiveness and safety of minimally invasive laparoscopic living donor nephrectomy in comparison with standard laparoscopic living donor nephrectomy

By: Abdelwahhab M., Ghoneima W., El Shenoufy A., Morsi H., Abo El Fettouh H., El Gammal M.

Institutes: Cairo University Hospitals, Dept. of Urology, Cairo, Egypt

1008
Impact of an additional trocar on clinical outcome, inflammatory cytokines, and cosmetic satisfaction in laparoendoscopic single-site donor nephrectomy

By: Saito M.1, Inoue T.1, Narita S.1, Tsuruta H.1, Maeno A.1, Numakura K.1, Satoh S.2, Habuchi T.1

Institutes: 1Akita University School of Medicine, Dept. of Urology, Akita, Japan, 2Akita University School of Medicine, Center For Kidney Disease and Transplantation, Akita, Japan

1009
Visceral obesity in living kidney Asian donors significantly impacts on renal function after donor nephrectomy

By: Pek X.W.G.1, Ngoh L.Y.C.2, Teo B.W.3, Vathsala A.3, Goh Y.S.B.4, Yong H.R.C.5, Raman L.N.M.4, Tiong H.Y.4

Institutes: 1University College Dublin, UCD School of Medicine and Medical Sciences, Dublin, Ireland, 2National University Hospital, Dept. of Medicine, University Medicine Cluster, Singapore, Singapore, 3National University Hospital, Dept. of Nephrology, University Medicine Cluster, Singapore, Singapore, 4National University Hospital, Dept. of Urology, University Surgical Cluster, Singapore, Singapore, 5National University Hospital, Dept. of Diagnostic Radiology, Singapore, Singapore

1010
Local sildenafil accelerate renal regeneration after ischemia/reperfusion injury in canine model

By: Zahran M.1, Barakat N.1, Khater S.2, Awadalla A.2, Fakhreldin I.1, Mosbah A.1, Nabeeh A.1, Shokeir A.1

Institutes: 1Urology and Nephrology Center, Dept. of Urology, Mansoura, Egypt, 2Urology and Nephrology Center, Dept. of Pathology, Mansoura, Egypt

1011
Impact of renal graft volume in the renal function of patients who undergo kidney transplantation

By: Ordones F.1, Kawano P.2, Guerra R.3, Yamamoto H.3, Modelli De Andrade L.G.4, Amaro J.L.3

Institutes: 1Royal Adelaide Hospital, Dept. of Urology, Adelaide, Australia, 2Botucatu Medical School – Sao Paulo State University, Dept. of Urology, Botucatu, Brazil, 3Botucatu Medical School – Sao Paulo State University – UNESP, Dept. of Urology, Botucatu, Brazil, 4Botucatu Medical School – Sao Paulo State University – UNESP, Dept. of Nephrology, Botucatu, Brazil

1012
Choosing the larger kidney on CT volumetry – a study on the early post-donation kidney function of living donors

By: Lynnette R.1, Goh Y.1, Tai B.C.2, Raman L.1, Vathsala A.3, Tiong H.Y.1

Institutes: 1National University Health System, Dept. of Urology, Singapore, Singapore, 2National University of Singapore, Dept. of Public Health, Singapore, Singapore, 3National University Health System, Dept. of Nephrology, Singapore, Singapore

1013
Kidney transplantation from uncontrolled donation after circulatory death (IIa): Organ procurement and renal harvested over a ten year period

By: Medina Polo J., Justo-Quintas J., Gil-Moradillo J., De La Rosa-Kehrmann F., Pamplona-Casamayor M., Rodríguez-Antolín A., Duarte-Ojeda J.M., Tejido-Sánchez A., Villacampa-Aubá F., Sopeña-Sutil R., Benitez-Sala R., Guerrero-Ramos F., Andrés-Belmonte A., Passas-Martínez J.B.

Institutes: Hospital Universitario 12 de Octubre, Dept. of Urology, Madrid, Spain

1014
Initial experience and results in kidney transplants in controlled asystolia donors in a single institution

By: Calaf Perisé O.1, Areal Calama J.1, González Satué C.1, Juega Mariño J.2, Pérez Mir M.2, Ibarz Servio L.1

Institutes: 1Hospital Universitari Germans Trias i Pujol, Dept. of Urology, Badalona, Spain, 2Hospital Universitari Germans Trias i Pujol, Dept. of Nephrology, Badalona, Spain

1015
Implementation of a donation and transplantation after controlled cardiac death (CCD) program in a Spanish university hospital. Results on renal graft and recipient survival

By: Trilla Herrera E.1, Sandiumenge A.2, Lorente D.1, Moreso F.3, Perelló M.3, Mazo C.4, Chamoun B.3, Ruiz-Rodriguez J.C.4, Gracia R.M.4, Espinel E.3, Pont T.2, Morote J.1

Institutes: 1Hospital Universitari Vall d’Hebron, Dept. of Urology, Barcelona, Spain, 2Hospital Universitari Vall d’Hebron, Dept. of Trasplant Coordination, Barcelona, Spain, 3Hospital Universitari Vall d’Hebron, Dept. of Nephrology, Barcelona, Spain, 4Hospital Universitari Vall d’Hebron, Dept. of Intensive Care, Barcelona, Spain